Clinical Trial Update: Cellular Senescence and COVID-19 Long-Hauler Syndrome

View source ↗

Summary

Mayo Clinic is conducting a clinical trial on cellular senescence and long-hauler COVID-19 (SARS-CoV-2 infection); the study (NCT04903132) is currently active a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Mayo Clinic | Conditions: SARS-CoV2 Infection | Status: ACTIVE_NOT_RECRUITING